A rating of 87 puts Capricor Therapeutics Inc (CAPR) near the top of the Biotechnology industry according to InvestorsObserver. Capricor Therapeutics Inc's score of 87 means it scores higher than 87% of stocks in the industry. Capricor Therapeutics Inc also received an overall rating of 64, putting it above 64% of all stocks. Biotechnology is ranked 77 out of the 148 industries.
CAPR has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on CAPR!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Capricor Therapeutics Inc Stock Today?
Capricor Therapeutics Inc (CAPR) stock is down -41.87% while the S&P 500 has risen 0.6% as of 9:54 AM on Friday, Sep 29. CAPR is lower by -$2.43 from the previous closing price of $5.82 on volume of 393,459 shares. Over the past year the S&P 500 is up 18.82% while CAPR is lower by -43.00%. CAPR lost -$1.17 per share the over the last 12 months.
Click Here to get the full Stock Report for Capricor Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
